A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
about
Ocular Complications of Diabetes and Therapeutic ApproachesIntraocular Implants for the Treatment of Autoimmune UveitisIntraocular pressure changes: an important determinant of the biocompatibility of intravitreous implantsExtended latanoprost release from commercial contact lenses: in vitro studies using corneal modelsBiomedical Imaging in Implantable Drug Delivery Systems.Meclofenamic acid improves the signal to noise ratio for visual responses produced by ectopic expression of human rod opsinPlanar microdevices enhance transport of large molecular weight molecules across retinal pigment epithelial cells.Single compartment drug delivery.Recent advances in ophthalmic drug delivery.Design and development of intraocular polymeric implant systems for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditisWhole vitreous humor dissection for vitreodynamic analysisElevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management.Reservoir-based drug delivery systems utilizing microtechnology.A microparticle/hydrogel combination drug-delivery system for sustained release of retinoids.Subconjunctivally Implanted Hydrogels for Sustained Insulin Release to Reduce Retinal Cell Apoptosis in Diabetic RatsAdvances in ocular drug delivery.Novel engineered systems for oral, mucosal and transdermal drug delivery.Critical assessment of implantable drug delivery devices in glaucoma management.Implantable microchip: the futuristic controlled drug delivery system.Intravitreal drug delivery in retinal disease: are we out of our depth?Ocular drug delivery systems: An overview.Ocular delivery systems for topical application of anti-infective agents.Drug-Eluting Intraocular Lenses.Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration.Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy.Ocular pharmacokinetic study using T₁ mapping and Gd-chelate- labeled polymersDevelopment, characterizations and biocompatibility evaluations of intravitreal lipid implants.Thermoanalytical characterization of clindamycin-loaded intravitreal implants prepared by hot melt extrusion.High Throughput Screening of Valganciclovir in Acidic Microenvironments of Polyester Thin Films.Principles of pharmacology in the eye.Preliminary study of a controllable device for subtenon drug infusion in a rabbit model.Chitosan electrodeposition for microrobotic drug delivery.Polymeric Materials in Ocular Drug Delivery Systems
P2860
Q26749412-1D28CEA3-B469-4935-99FC-B2BEE24625C6Q26799168-6C1BF779-D334-4063-9C53-23B37772EC8EQ28478420-459F287F-CAC0-4A48-944C-269BD20B4F96Q28542904-786487D9-F1D3-47E2-A45A-9A93BEFDEA6AQ30394673-85F96768-65B4-49EF-87AA-07482DAD2280Q33822189-B4C687BA-1165-4FEF-9F2E-D8896CFE4257Q33849404-EE34CE73-630F-4EE8-A59A-A76C4471A4CBQ34263907-6C1786D3-AFD7-4695-BFF0-946370B0CB73Q34636338-20B4932D-AD47-4D36-92AF-A85D2074BA0FQ35098278-35E69713-59A7-4284-83A1-655DECAEF0B3Q35940002-AB60FDAF-DB2F-43AB-82C6-6DA64680908CQ36013578-3FBCC3C5-F84E-484D-8341-96E7DA5EFD24Q36198990-AFEAAACA-0303-4E5F-93F4-951D1EF612E7Q36299877-6A41A60E-3888-4549-BF27-5DF2B42AC333Q36380233-0E9F1710-F30B-40BE-B613-D838F3A41E37Q38003192-48231345-E229-4890-A9A3-90652AB3C73CQ38122744-00D8E118-0FBA-4EAF-809C-29746D1AE21BQ38143069-BBACFA2E-1461-432A-BC4F-34523D4DCEF2Q38206542-722DE391-ECF4-42C6-A5BB-509E578E18C2Q38220453-A697EF9C-7D2E-4CAD-9122-F972D4677AE8Q38318837-A34A2F13-0718-4FDA-80E1-E7BDF3B7C3E8Q38577846-E39FD1B7-8527-4E25-8459-796E91D8E82EQ38616937-FD487512-DD0A-4D14-9BF9-D00E2A00D6CEQ38837906-3AE5B5CF-8625-4110-9519-DEA71F7F8A39Q38895113-A7311EF1-01A3-47CD-A90C-2555A0B3DD71Q39604267-8B4350B8-0D77-4E8B-8FA2-D509C78AF370Q40000461-1198B04D-0673-4999-BE6B-6D267EDD7163Q40591341-AEA68A44-57D4-40F3-8951-CCF38BD717D6Q40992924-65D7FA3E-6723-4FD6-B28B-CB8069A6B443Q45871474-AAF6E2E5-77A7-4298-A408-028E7C86EBA7Q48300017-6E0E9447-E6B2-426A-9F5B-16D26596461AQ50484799-84E3E153-B9FB-4A2C-A0BD-B68F48B23D9AQ58436049-9FC0752F-141A-4B8F-BF1A-CCA4C27EF94E
P2860
A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A review of implantable intrav ...... osterior segment eye diseases.
@en
A review of implantable intrav ...... osterior segment eye diseases.
@nl
type
label
A review of implantable intrav ...... osterior segment eye diseases.
@en
A review of implantable intrav ...... osterior segment eye diseases.
@nl
prefLabel
A review of implantable intrav ...... osterior segment eye diseases.
@en
A review of implantable intrav ...... osterior segment eye diseases.
@nl
P50
P356
P1476
A review of implantable intrav ...... osterior segment eye diseases.
@en
P2093
Michael P Danckwerts
Trevor R Carmichael
P304
P356
10.1002/JPS.21987
P407
P577
2010-05-01T00:00:00Z